Author: Jacob Kames; David Dillon Holcomb; Ofer Kimchi; Michael DiCuccio; Nobuko Hamasaki-Katagiri; Tony Wang; Anton A Komar; Aikaterini Alexaki; Chava Kimchi-Sarfaty
Title: Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design Document date: 2020_3_31
ID: 2fn25l6m_19
Snippet: We performed a comprehensive characterization of the codon, codon pair and dinucleotide usage of the SARS-CoV-2 genome with the intention to identify the best targets for codon pair deoptimization in order to design an attenuated virus for vaccine development. Genes N and S were singled out as the best potential targets for deoptimization, due to the relatively high CPB among the viral genes. The copyright holder for this preprint (which was not .....
Document: We performed a comprehensive characterization of the codon, codon pair and dinucleotide usage of the SARS-CoV-2 genome with the intention to identify the best targets for codon pair deoptimization in order to design an attenuated virus for vaccine development. Genes N and S were singled out as the best potential targets for deoptimization, due to the relatively high CPB among the viral genes. The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.30.016832 doi: bioRxiv preprint Furthermore, they are structural proteins with known functions. Therefore, it will be possible to study the results of codon pair deoptimization on the fitness of the virus.
Search related documents:
Co phrase search for related documents- known function and potential target: 1, 2, 3, 4, 5
- known function and structural protein: 1, 2, 3, 4, 5, 6, 7
- known function and vaccine development: 1, 2
- known function and viral gene: 1, 2, 3, 4
- known function and virus fitness: 1
- pair deoptimization and vaccine development: 1, 2, 3, 4, 5, 6, 7
- pair deoptimization and vaccine development attenuated virus: 1, 2
- pair deoptimization and viral gene: 1, 2, 3
- pair deoptimization and virus fitness: 1, 2
- potential target and structural protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46
- potential target and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
- potential target and viral gene: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- structural protein and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- structural protein and viral gene: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
- structural protein and virus fitness: 1, 2, 3
- vaccine development and viral gene: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- vaccine development and virus fitness: 1, 2, 3, 4, 5
- vaccine development attenuated virus and viral gene: 1
- viral gene and virus fitness: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date